Cataracts, a common eye condition characterized by clouding of the lens, often lead to blurred vision and, if left untreated, ...

Multiple sclerosis (MS) is one of the most widespread disabling neurological conditions of young adults around the world. It affects almost 1 million people in the United States, and about 2.9 ...

clearance to a Bay Area commercial stage medical technology company for its novel large-bore catheter stroke thrombectomy system. In a press release, device manufacturer Imperative Care Inc. said ...

They include an October 2022 order to test Medicare and Medicaid models that could lower health care costs ... of a Gender Policy Council, and multiple gender and sex discrimination protections.

The first catheter change should ideally be performed under the care of a urology team; subsequent changes at intervals of 3 months can be carried out by district or practice nurses.

Researchers don’t yet fully understand what causes multiple sclerosis (MS) but believe it may develop from a combination of genetic and environmental factors. Identifying these factors can help ...

He previously worked at Android Police and Tech Advisor. Google’s AI assistant Gemini is now able to carry out tasks across multiple apps in a single interaction, in an update announced today ...

College of Chemistry, Jilin Province Research Center for Engineering and Technology of Spectral Analytical Instruments, Jilin University, Changchun 130012, China College of Chemistry and Material ...

Although AI can potentially improve the quality of OC care, current limitations in image ... blood loss, diabetes, catheter, catheter intubation times, and hypoproteinemia as the most important ...

During his departure announcement in 2024, Neil thanked his bosses for their patience when he took off “a day or two here and there battling everything from multiple sclerosis and COVID to ...

A failing care home where standards have been branded "completely unacceptable" has been placed in special measures to protect its residents. The Care Quality Commission has taken action to ...

Saad Z. Usmani, MD, MBA, FACP, discusses noteworthy data presented at ASH 2024, including the IFM2017-03 trial, and shares his excitement for ongoing research efforts in multiple myeloma ...